Danyelle M. Townsend | |
---|---|
Occupation(s) | Biomedical scientist and academic |
Academic background | |
Education | BS., Biology and Mathematics MS., Molecular Genetics PhD., Cell Biology |
Alma mater | George Mason University, Virginia University of Virginia School of Medicine |
Academic work | |
Institutions | Medical University of South Carolina (MUSC) |
Danyelle M. Townsend is a biomedical scientist,and academic. She is a Professor and acting Department Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina (MUSC). [1]
Townsend's lab utilizes proteomics and analytical biochemistry to identify molecular targets affected by oxidative and nitrosative stress,exploring the impact of redox signaling on cellular responses. Her research on the redox proteome and associated pathways has contributed to drug discovery and redox biomarker development. [2]
Townsend has authored over 150 peer-reviewed publications including journal articles,book chapters,and co-edited a book titled,Redox and Cancer Part A. In addition,she served as Co-Editor for Biomedicine and Pharmacotherapy from 2014 to 2015,and has been the Editor-in-Chief for this journal since 2015. [2]
In 1993,Townsend graduated from George Mason University with a Bachelor of Science in Biology and Mathematics. She went on to earn a Master of Science in Molecular Genetics from the same university. She received a doctoral degree from the University of Virginia School of Medicine where she focused on cancer cell biology and metabolism. From 2001 to 2004,she served as a post-doctoral fellow in Pharmacology and Experimental Therapeutics at Fox Chase Cancer Center. [3]
Townsend held various academic positions at the Medical University of South Carolina,starting as a Research Assistant Professor (2004) in the Department of Pharmaceutical Sciences. She was appointed as an associate professor in the Drug Discovery and Biomedical Sciences department in 2015 and has been serving as a Professor [1] and acting department chair. [4]
In 2021,Townsend became the co-director of the Administrative Core for the Redox COBRE. [5]
Townsend's research has combined advanced proteomics and drug metabolism with biochemistry to identify molecular targets affected by oxidative and nitrosative stress. Her lab has focused on understanding the events leading to the endoplasmic reticulum (ER) stress response,specifically examining stress-induced impacts on proteins involved in protein folding. [6] Her publication record includes an H-index of over 50,with more than 13,000 citations. [7]
Townsend's research has focused on the multifaceted role of glutathione and glutathione S-transferase (GST) in human disease,particularly their involvement in anti-cancer drug resistance,protein S-glutathionylation,and redox stress. She explored GSH's role in maintaining cellular balance,serving as a co-factor for enzymes,and influencing posttranslational modifications. This work emphasized GSH's crucial role in combating reactive oxygen species (ROS),implicated in diseases such as cancer,neurodegenerative diseases,cystic fibrosis (CF),HIV,and aging. [8] Collaborating with Tew,she investigated the role of GSTs in the development of resistance to chemotherapy agents,proposing them as inhibitors of the MAP kinase pathway and potential therapeutic targets for various diseases,including neurodegenerative diseases,multiple sclerosis,and asthma. [9] Her studies identified a role for GSTs as enzymatic mediators of S-glutathionylation of proteins. In her further research on cancer chemotherapy,she explored how cisplatin selectively kills proximal tubule cells,identified its metabolic pathway to a nephrotoxin,and showed that the metabolism in these cells is crucial for cisplatin-induced kidney damage,suggesting new targets for inhibition. [10]
Townsend has made contributions to the field of biochemistry,particularly in the context of oxidative stress,redox regulation,and their implications in various diseases. Exploring the impact of oxidative stress and redox regulation on cellular differentiation,she investigated their role in diseases associated with abnormal cell differentiation. [11] In a collaborative study with Tapiero and Tew,she provided details on carotenoids as dietary antioxidants,highlighting their role in preventing cancer and cardiovascular diseases by mitigating oxidative damage and promoting intercellular communication. [12] She also identified S-glutathionylation as a cell stress indicator and unfolded protein response regulator,linking it to pathologies and potential therapies influenced by oxidative stress and endoplasmic reticulum redox conditions. [13] In another joint study,her work delved into the role of cysteine S-glutathionylation in redox cell signaling,proposing it as a biomarker for oxidative/nitrosative stress and its utility for individuals exposed to stress-inducing agents affecting protein clusters. [14]
Townsend's research has discussed the multifaceted role of glutathione S-transferase P (GSTP) in mediating S-glutathionylation,negatively regulating kinase pathways,and contributing to cellular redox homeostasis,with implications for drug development. [15] She has also been involved in creating a new zebrafish model to study the role of glutathione S-transferase π1 in development,redox homeostasis,and drug response involving cytotoxicity through endoplasmic reticulum stress and unfolded protein response. [16] Additionally,in an Antioxidants &Redox Signaling review,she analyzed the influence of the S-glutathionylation cycle on protein structure,cellular regulation,and its significance for interventions in stress- and aging-related pathologies. [17] Furthermore,her research has demonstrated that altered GSTP expression within the endoplasmic reticulum regulates protein homeostasis (proteostasis) through S-glutathionylation of ER resident proteins,including PDI and BiP. GSTP leads to S-glutathionylation of binding immunoglobulin protein (BiP),contributing to acquired resistance to Btz in multiple myeloma (MM) cells,representing a novel mechanism of drug resistance in MM. [18] She has also emphasized GSTπ's novel role in enhancing S-glutathionylation reactions under oxidative and nitrosative stress,with implications for stress response and drug resistance in tumors. [19]
More recently,Townsend's research has shown the potential of the nanomolar GSTP inhibitor TLK199 (Telintra;Ezatiostat) for treating myelodysplastic syndrome and influencing hematopoiesis. [20] Her work has also revealed the embryonic lethality of MGST1 deletion in mice and the significance of MGST1 in vertebrate embryonic development and hematopoiesis,as shown through zebrafish knockdown. [21] Moreover,she has highlighted the evolutionary conservation of mito-ncR-805 retrograde signaling,suggesting therapeutic applications for enhancing mitochondrial bioenergetics. [22] In related research on C57 BL/6 mice,DSBA was found to prevent ionizing radiation-induced suppression of bone marrow hematopoietic cells for the first time,indicating its potential as a radioprotective or preventive agent in cancer treatment. [23]
Antioxidants are compounds that inhibit oxidation,a chemical reaction that can produce free radicals. Autoxidation leads to degradation of organic compounds,including living matter. Antioxidants are frequently added to industrial products,such as polymers,fuels,and lubricants,to extend their usable lifetimes. Foods are also treated with antioxidants to forestall spoilage,in particular the rancidification of oils and fats. In cells,antioxidants such as glutathione,mycothiol,or bacillithiol,and enzyme systems like superoxide dismutase,can prevent damage from oxidative stress.
Coenzyme A (CoA,SHCoA,CoASH) is a coenzyme,notable for its role in the synthesis and oxidation of fatty acids,and the oxidation of pyruvate in the citric acid cycle. All genomes sequenced to date encode enzymes that use coenzyme A as a substrate,and around 4% of cellular enzymes use it (or a thioester) as a substrate. In humans,CoA biosynthesis requires cysteine,pantothenate (vitamin B5),and adenosine triphosphate (ATP).
Glutathione is an organic compound with the chemical formula HOCOCH(NH2)CH2CH2CONHCH(CH2SH)CONHCH2COOH. It is an antioxidant in plants,animals,fungi,and some bacteria and archaea. Glutathione is capable of preventing damage to important cellular components caused by sources such as reactive oxygen species,free radicals,peroxides,lipid peroxides,and heavy metals. It is a tripeptide with a gamma peptide linkage between the carboxyl group of the glutamate side chain and cysteine. The carboxyl group of the cysteine residue is attached by normal peptide linkage to glycine.
In chemistry and biology,reactive oxygen species (ROS) are highly reactive chemicals formed from diatomic oxygen (O2),water,and hydrogen peroxide. Some prominent ROS are hydroperoxide (O2H),superoxide (O2-),hydroxyl radical (OH.),and singlet oxygen. ROS are pervasive because they are readily produced from O2,which is abundant. ROS are important in many ways,both beneficial and otherwise. ROS function as signals,that turn on and off biological functions. They are intermediates in the redox behavior of O2,which is central to fuel cells. ROS are central to the photodegradation of organic pollutants in the atmosphere. Most often however,ROS are discussed in a biological context,ranging from their effects on aging and their role in causing dangerous genetic mutations.
4-Hydroxynonenal,or 4-hydroxy-2E-nonenal or 4-hydroxy-2-nonenal or 4-HNE or HNE,,is an α,β-unsaturated hydroxyalkenal that is produced by lipid peroxidation in cells. 4-HNE is the primary α,β-unsaturated hydroxyalkenal formed in this process. It is a colorless oil. It is found throughout animal tissues,and in higher quantities during oxidative stress due to the increase in the lipid peroxidation chain reaction,due to the increase in stress events. 4-HNE has been hypothesized to play a key role in cell signal transduction,in a variety of pathways from cell cycle events to cellular adhesion.
Glutathione S-transferases (GSTs),previously known as ligandins,are a family of eukaryotic and prokaryotic phase II metabolic isozymes best known for their ability to catalyze the conjugation of the reduced form of glutathione (GSH) to xenobiotic substrates for the purpose of detoxification. The GST family consists of three superfamilies:the cytosolic,mitochondrial,and microsomal—also known as MAPEG—proteins. Members of the GST superfamily are extremely diverse in amino acid sequence,and a large fraction of the sequences deposited in public databases are of unknown function. The Enzyme Function Initiative (EFI) is using GSTs as a model superfamily to identify new GST functions.
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and a biological system's ability to readily detoxify the reactive intermediates or to repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell,including proteins,lipids,and DNA. Oxidative stress from oxidative metabolism causes base damage,as well as strand breaks in DNA. Base damage is mostly indirect and caused by the reactive oxygen species generated,e.g.,O2− (superoxide radical),OH (hydroxyl radical) and H2O2 (hydrogen peroxide). Further,some reactive oxidative species act as cellular messengers in redox signaling. Thus,oxidative stress can cause disruptions in normal mechanisms of cellular signaling.
Glutathione synthetase (GSS) is the second enzyme in the glutathione (GSH) biosynthesis pathway. It catalyses the condensation of gamma-glutamylcysteine and glycine,to form glutathione. Glutathione synthetase is also a potent antioxidant. It is found in many species including bacteria,yeast,mammals,and plants.
Leukotriene C4 (LTC4) is a leukotriene. LTC4 has been extensively studied in the context of allergy and asthma. In cells of myeloid origin such as mast cells,its biosynthesis is orchestrated by translocation to the nuclear envelope along with co-localization of cytosolic phospholipase A2 (cPLA2),arachidonate 5-lipoxygenase (5-LO),5-lipoxygenase-activating protein (FLAP) and LTC4 synthase (LTC4S),which couples glutathione to an LTA4 intermediate. The MRP1 transporter then secretes cytosolic LTC4 and cell surface proteases further metabolize it by sequential cleavage of the γ-glutamyl and glycine residues off its glutathione segment,generating the more stable products LTD4 and LTE4. All three leukotrienes then bind at different affinities to two G-protein coupled receptors:CYSLTR1 and CYSLTR2,triggering pulmonary vasoconstriction and bronchoconstriction.
Glutathione S-transferase P is an enzyme that in humans is encoded by the GSTP1 gene.
Nuclear factor erythroid 2-related factor 2 (NRF2),also known as nuclear factor erythroid-derived 2-like 2,is a transcription factor that in humans is encoded by the NFE2L2 gene. NRF2 is a basic leucine zipper (bZIP) protein that may regulate the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation,according to preliminary research. In vitro,NRF2 binds to antioxidant response elements (AREs) in the promoter regions of genes encoding cytoprotective proteins. NRF2 induces the expression of heme oxygenase 1 in vitro leading to an increase in phase II enzymes. NRF2 also inhibits the NLRP3 inflammasome.
Glutathione S-transferase Mu 4 is an enzyme that in humans is encoded by the GSTM4 gene.
Glutaredoxin 2 (GLRX2) is an enzyme that in humans encoded by the GLRX2 gene. GLRX2,also known as GRX2,is a glutaredoxin family protein and a thiol-disulfide oxidoreductase that maintains cellular thiol homeostasis. This gene consists of four exons and three introns,spanned 10 kilobase pairs,and localized to chromosome 1q31.2–31.3.
Glutathione S-transferase kappa 1 (GSTK1) is an enzyme that in humans is encoded by the GSTK1 gene which is located on chromosome seven. It belongs to the superfamily of enzymes known as glutathione S-transferase (GST),which are mainly known for cellular detoxification. The GSTK1 gene consists of eight exons and seven introns and although it is a member of the GST family,its structure has been found to be similar to bacterial HCCA (2-hydroxychromene-2-carboxylate) isomerases and bacterial disulphide-bond-forming DsbA oxidoreductase. This similarity has later allowed the enzyme GSTK1 to be renamed to DsbA-L. Research has also suggested that several variations of the GSTK1 gene can be responsible for metabolic diseases and certain types of cancer.
The reduction-oxidation sensitive green fluorescent protein (roGFP) is a green fluorescent protein engineered to be sensitive to changes in the local redox environment. roGFPs are used as redox-sensitive biosensors.
The ascorbate-glutathione cycle,sometimes Foyer-Halliwell-Asada pathway,is a metabolic pathway that detoxifies hydrogen peroxide (H2O2),a reactive oxygen species that is produced as a waste product in metabolism. The cycle involves the antioxidant metabolites:ascorbate,glutathione and NADPH and the enzymes linking these metabolites.
Bacterial glutathione transferases are part of a superfamily of enzymes that play a crucial role in cellular detoxification. The primary role of GSTs is to catalyze the conjugation of glutathione (GSH) with the electrophilic centers of a wide variety of molecules. The most commonly known substrates of GSTs are xenobiotic synthetic chemicals. There are also classes of GSTs that utilize glutathione as a cofactor rather than a substrate. Often these GSTs are involved in reduction of reactive oxidative species toxic to the bacterium. Conjugation with glutathione receptors renders toxic substances more soluble,and therefore more readily exocytosed from the cell.
In molecular biology,the glutaredoxin 2 family is a family of bacterial glutaredoxins. Unlike other glutaredoxins,glutaredoxin 2 (Grx2) cannot reduce ribonucleotide reductase. Grx2 has significantly higher catalytic activity in the reduction of mixed disulphides with glutathione (GSH) compared with other glutaredoxins. The active site residues (Cys9-Pro10-Tyr11-Cys12,in Escherichia coli Grx2,which are found at the interface between the N- and C-terminal domains are identical to other glutaredoxins,but there is no other similarity between glutaredoxin 2 and other glutaredoxins. Grx2 is structurally similar to glutathione-S-transferases,but there is no obvious sequence similarity. The inter-domain contacts are mainly hydrophobic,suggesting that the two domains are unlikely to be stable on their own. Both domains are needed for correct folding and activity of Grx2. It is thought that the primary function of Grx2 is to catalyse reversible glutathionylation of proteins with GSH in cellular redox regulation including the response to oxidative stress. These enzymes are not related to GLRX2.
Reductive stress (RS) is defined as an abnormal accumulation of reducing equivalents despite being in the presence of intact oxidation and reduction systems. A redox reaction involves the transfer of electrons from reducing agents (reductants) to oxidizing agents (oxidants) and redox couples are accountable for the majority of the cellular electron flow. RS is a state where there are more reducing equivalents compared to reductive oxygen species (ROS) in the form of known biological redox couples such as GSH/GSSG,NADP+/NADPH,and NAD+/NADH. Reductive stress is the counterpart to oxidative stress,where electron acceptors are expected to be mostly reduced. Reductive stress is likely derived from intrinsic signals that allow for the cellular defense against pro-oxidative conditions. There is a feedback regulation balance between reductive and oxidative stress where chronic RS induce oxidative species (OS),resulting in an increase in production of RS,again.
Kenneth D. Tew is a Scottish-American pharmacologist,academic and author. He is a professor in the Department of Cell &Molecular Pharmacology and the John C. West Endowed Chair in Cancer Research at the Medical University of South Carolina.
This article needs additional or more specific categories .(February 2024) |